Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Resverlogix Corp (OTC Pink - Current Information:RVXCF)

1.68
Delayed Data
As of Dec 11
 -0.025 / -1.47%
Today’s Change
0.92
Today|||52-Week Range
1.91
+31.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$297.6M

Company Description

Resverlogix Corp. is a clinical stage biotechnology company, which engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan and Alzheimer's diseases. The company was founded by Donald J. McCaffrey and Norman C. W. Wong on August 17, 2000 and is headquartered in Calgary, Canada.

Contact Information

Resverlogix Corp.
4820 Richard Road SW
Calgary Alberta T3E 6L1
P:(403) 254-9252
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Donald J. McCaffreyChairman, President, CEO & Secretary
Anthony Brad CannChief Financial Officer
Norman C. W. WongChief Scientific Officer
Jan O. JohanssonSenior Vice President-Medical Affairs
Ewelina KulikowskiSenior Vice President-Scientific Development